CLOUDBREAK-B (02592.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec15

Puckcom Vision Cloud-B Submits CBT-199 New Drug Clinical Trial Application

09:17

Dec12

Cloudbreak USA held a Phase 2 Clinical Trial Meeting with FDA for CBT-004

08:38

Dec8

Cloudbreak USA to Hold Post-Phase 2 Clinical Trial Meeting with FDA

04:24

Nov26

KonSiYun Shares Latest Clinical Progress of CBT-001 and CBT-004 at Ophthalmic Innovation Summit

07:37

Aug29

CLOUDBREAK-B released FY2025 Semi-Annual Earnings on August 29 BJT with actual revenue HKD 0 and actual EPS HKD -0.3346

15:00

CLOUDBREAK-B released FY2024 Semi-Annual earnings on August 29, 2025 (BJT) with actual revenue of HKD 0 and EPS of HKD -0.8598

15:00

Schedules & Filings

Schedules

Filings

Aug29

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 109.9 K, Net Income 20.35 M, EPS -0.168

Jul3

IPO(CST)

Listing Price HKD 10.1

Jun23

Earning Release(CST)

FY2024 Annual Earning Release (HKD) Revenue 79.6 M, Net Income -772.56 M, EPS -1.6251

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change